The C. elegans meetings calendar

Name: ACT AM2024 – American College of Toxicology
Start: 2024-11-17T00:00:00-06:00
End: 2024-11-20T00:00:00-06:00
Location: Austin, TX

Your source for upcoming meetings of C. elegans scientists, courtesy of vivoVerse.

vivoVerse is happy to provide this worm meeting calendar, tracking upcoming local, regional, national, and international meetings of C. elegans scientists. We regularly update the list to keep you informed about upcoming events and conferences that matter most to the C. elegans community. Stay ahead, network, and thrive in the vibrant C. elegans research community with vivoVerse.

Do you have an event for the worm community you’d like to promote? Send us an email at support@vivoverse.com and we’ll add it to our calendar.

Filters

Event type
Show all meetings

Region
North America
Europe
India

ACT2024

November 2024
ACT AM2024 – American College of Toxicology

November 17, 2024 @ 12:00 am - November 20, 2024 @ 12:00 am

Austin, TX 110 E 2nd St, Austin, United States

The ACT 45th Annual Meeting will occur November 17–20, 2024, at the JW Marriott Hotel in Austin, Texas. The Annual Meeting is the heart of ACT.

vivoVerse provides solutions for high-throughput, high-content imaging of C. elegans to the community.

The vivoChip-2x allows rapid immobilization of 40 animals in the lateral orientation directly from a plate within minutes, for high-resolution live imaging on any microscope.

vivoScreen is a complete automated high-throughput, high-content imaging system for C. elegans researchers enabling automated high-resolution imaging of up to 24 individual populations of 40 worms each with software allowing rapid analysis of custom phenotypes.

Meeting Locations

Sudip Mondal, Director of Science

Dr. Sudip Mondal has a Ph.D. in Physics and several years of postdoctoral research experience in neuroscience and microfluidics-based screening tools. He has developed several technologies that have translated to the market. One of his recent works at The University of Texas at Austin involved a high-throughput screening platform with C. elegans model systems, which is commercialized by vivoVerse. As a Director of Science, Sudip is responsible for developing new technologies and innovative assays to increase the vivoVerse product & service portfolio.

Evan Hegarty, MSE

Evan Hegarty, co-founder, received his M.S. in Mechanical Engineering at The University of Texas at Austin while developing the technology and IP that lead to the launch of Newormics, LLC, now vivoVerse. As the Director of Manufacturing and Product development, and Principal Investigator of NIH SBIR grants at vivoVerse, Evan is responsible for development of all chip and system designs, creating production schedules, optimizing production methods, managing team members, identifying customer needs, developing future products, and reinforcing GLP and GMP.

Adela Ben-Yakar, PhD

A professor with dual appointments in Mechanical Engineering and Biomedical Engineering at The University of Texas at Austin, Dr Ben-Yakar’s research focuses on the creation of imaging technologies and novel laser surgery with high precision. Educated at Stanford and the Technion in Israel, with post-doctoral study at Harvard, and using her NIH Director’s Transformative Research Award, Dr Ben-Yakar began the research that has culminated in the launch of vivoVerse (formerly Newormics)